Subtitle
Osteoradionecrosis in Pediatric Patients Treated with Proton Therapy for Head and Neck Malignancies.
Subtitle
Osteoradionecrosis in Pediatric Patients Treated with Proton Therapy for Head and Neck Malignancies.
Proto therapy Time
December 2024
Executive summary
This retrospective analysis from MD Anderson included 117 pediatric patients treated with proton therapy for head and neck cancers among which the most common histology was rhabdomyosarcoma (46%), and the most common involved sites were the parameningeal sites (44%) and the orbit (32%). This study reported two (1.7%) patients who developed osteoradionecrosis.
Top cancer treatments
Related contents
Proton Therapy Publication

May 2025
Long-Term Outcomes Following Radiotherapy for Pediatric Salivary Gland Tumors.
en
Proton Therapy Publication

February 2025
Proton or photon? Comparison of survival and toxicity of two radiotherapy modalities among pediatric brain cancer patients: A systematic review and meta-analysis
en
Podcast

February 19, 2025
The Exciting Future of Proton Therapy for Pediatric Patients
en
Proton Therapy Publication

November 2024
Proton beam therapy for craniopharyngioma: a systematic review and meta-analysis
en
Proton Therapy Publication

November 2024
Systematic review and meta-analysis of photon radiotherapy versus proton beam therapy for pediatric intracranial ependymoma: TRP-ependymoma 2024
en
Proton Therapy Publication

December 2024
Evaluating the safety and efficacy of proton radiotherapy for intracranial pediatric ependymomas: A single-arm meta-analysis.
en
Webinar

18 October 2024
Empowering Cancer Care with Proton Therapy
Rakesh
Jalali
Srinivas
Chilukuri
Daniela
Alterio
en
Proton Therapy Publication

September 2024
Outcomes of proton therapy to infradiaphragmatic sites in pediatric patients with Hodgkin lymphoma.
en
Proton Therapy Publication

September 2024
Long-term outcomes following proton therapy for pediatric spinal low-grade glioma.
en